Oncostatin M-induced effects on EMT in human proximal tubular cells: Differential role of ERK signaling

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 5, 2007, Pages

  Pollack, Verena ^a   Sarközi, Rita ^a   Banki, Zoltan ^b   Feifel, Elisabeth ^b   Wehn, Swantje ^d   Gstraunthaler, Gerhard ^b   Stoiber, Heribert ^b   Mayer, Gert ^a   Montesano, Roberto ^c   Strutz, Frank ^d   Schramek, Herbert ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; CALVASCULIN; CLAUDIN 2; COLLAGEN TYPE 1; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; NERVE CELL ADHESION MOLECULE; ONCOSTATIN M; STAT1 PROTEIN; STAT3 PROTEIN; UVOMORULIN; VIMENTIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 36048949007     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00130.2007     Document Type: Article

References (64)

1. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
2. Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C, Comoglio PM. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature 391: 285-288, 1998.
3. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116: 499-511, 2003.
4. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.
5. Carrozzino F, Soulié Huber D, Mensi N, Orci L, Cano A, Féraille E, Montesano R. Inducible expression of Snail selectively increases paracellular ion permeability and differentially modulates tight junction proteins. Am J Physiol Cell Physiol 289: C1002-C1014, 2005.
6. Chatziantoniou C, Dussaule JC. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol 289: F227-F234, 2005.
7. Christ B, Ordahl CP. Early stages of chick somite development. Anat Embryol (Berl) 191: 381-396, 1995.
8. Davis D, Schmid I. Detecting apoptosis. In: Living Colour: Protocols in Flow Cytometry and Cell Sorting, edited by Diamond RA and Demaggiopp S. Berlin: Springer, 2000, p. 377-384.
9. Eddy AA. Molecular insights into interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996.
10. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet 365: 331-340, 2005.
11. Enck AH, Berger UV, Yu AS. Claudin-2 is selectively expressed in proximal nephron in mouse kidney. Am J Physiol Renal Physiol 281: F966-F974, 2001.
12. Funayama N, Sato Y, Matsumoto K, Ogura T, Takahashi Y. Coelom formation: binary decision of the lateral plate mesoderm is controlled by the ectoderm. Development 126: 4129-4138, 1999.
13. Gómez-Lechón MJ. Oncostatin M: signal transduction and biological activity. Life Sci 65: 2019-2030, 1999.
14. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chrom Cancer 34: 255-268, 2002.
15. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779-790, 2000.
16. Healy E, Leonard M, Madrigal-Estebas L, O'Farrelly C, Watson AJ, Ryan MP. Factors produced by activated leukocytes alter renal epithelial cell differentiation. Kidney Int 56: 1266-1269, 1999.
17. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135: 1643-1654, 1996.
18. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
19. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761-769, 2001.
20. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
21. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 274: 26563-26571, 1999.
22. Lan M, Kojima T, Osanai M, Chiba H, Sawada N. Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line. Carcinogenesis 25: 2385-2395, 2004.
23. Lee DBN, Huang E, Ward HJ. Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 290: F20-F34, 2006.
24. Lipschutz JH, Li S, Arisco A, Balkovetz DF. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 280: 3780-3788, 2005.
25. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
26. Locascio A, Nieto MA. Cell movements during vertebrate development: integrated tissue behaviour versus individual cell migration. Curr Opin Genet Dev 11: 464-469, 2001.
27. Marschitz I, Lechner J, Mosser I, Dander M, Montesano R, Schramek H. Differential expression of cell-cell adhesion proteins and cyclin D in MEK1-transdifferentiated MDCK cells. Am J Physiol Cell Physiol 279: C1472-C1482, 2000.
28. Montesano R, Schaller G, Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66: 697-711, 1991.
29. Montesano R, Soriano JV, Hosseini G, Pepper MS, Schramek H. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Diff 10: 317-332, 1999.
30. Mullin JM, Leatherman JM, Valenzano MC, Huerta ER, Verrechio J, Smith DM, Snetselaar K, Liu M, Francis MK, Sell C. Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol Biol Cell 16: 5538-555, 2005.
31. Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle F, Foidart JM, Van Roy F, Birembaut P. E-cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol 163: 653-661, 2003.
32. Neilson EG. Mechanisms of disease: fibroblasts - a new look at an old problem. Nat Clin Pract Nephrol 2: 101-108, 2006.
33. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54: 864-876, 1998.
34. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644, 1999.
35. Nightingale J, Patel S, Suzuki N, Buxton R, Takagi KI, Suzuki J, Sumi Y, Imaizumi A, Mason RM, Zhang Z. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation. J Am Soc Nephrol 15: 21-32, 2004.
36. Nishimoto S, Nishida E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7: 782-786, 2006.
37. Nouwen EJ, Dauwe S, van der Biest I, De Broe ME. Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int 44: 147-158, 1993.
38. O'Brien LE, Zegers MM, Mostov KE. Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat Rev Mol Cell Biol 3: 531-537, 2002.
39. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol Renal Physiol 273: F563-F574, 1997.
40. Peinado H, Marin F, Cubillo E, Stark HJ, Fusenig N, Nieto MA, Cano A. Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci 117: 2827-2839, 2004.
41. Pollack V, Scheiber K, Pfaller W, Schramek H. Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines. Biochem Biophys Res Commun 241: 541-547, 1997.
42. Prozialeck WC, Lamar PC, Appelt DM. Differential expression of E-cadherin, N-cadherin and beta-catenin in proximal and distal segments of the rat nephron. BMC Physiol 4: 1-14, 2004.
43. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D'Amico G. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62: 137-146, 2002.
44. Reyes JL, Lamas M, Martin D, del Carmen NM, Islas S, Luna J, Taue M, Gonzalez-Mariscal L. The renal segmental distribution of claudins changes with development. Kidney Int 62: 476-487, 2002.
45. Rose TM, Lagrou MJ, Fransson I, Werelius B, Delattre O, Thomas G, de Jong PJ, Torado GJ, Dumanski JP. The genes for oncostatin M (OSM) and leukaemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics 17: 136-140, 1993.
46. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45: 48-57, 1994.
47. Sarközi R, Miller B, Pollack V, Feifel E, Mayer G, Sorokin A, Schramek H. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells. J Cell Physiol 211: 88-100, 2007.
48. Schramek H. MAP kinases: From intracellular signals to physiology and disease. News Physiol Sci 17: 62-67, 2002.
49. Schramek H, Feifel E, Healy E, Pollack V. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in Madin-Darby canine kidney-C7 cells. J Biol Chem 17: 11426-11433, 1997.
50. Schramek H, Feifel E, Marschitz I, Golochtchapova N, Gstraunthaler G, Montesano R. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. Am J Physiol Cell Physiol 285: C652-C661, 2003.
51. Schramek H, Sorokin A, Watson RD, Dunn MJ. Differential long-term regulation of MEK and of p42 MAPK in rat glomerular mesangial cells. Am J Physiol Cell Physiol 270: C40-C48, 1996.
52. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405, 1995.
53. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG. Role of basic fibroblast growth factor-2 in epithelial- mesenchymal transformation. Kidney Int 61: 1714-1728, 2002.
54. Tanaka M, Miyajima A. Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149: 39-52, 2003.
55. Tsuchiya B, Sato Y, Kameya T, Okayasu I, Mukai K. Differential expression of N-cadherin and E-cadherin in normal human tissues. Arch Histol Cytol 69: 135-145, 2006.
56. 1 cells: cloning of phenotypically stable subpopulations. Am J Physiol Cell Physiol 250: C682-C687, 1986.
57. Wohlwend A, Vassalli JD, Bertrand D, Orci L. Calcitonin and vasopressin affect epithelial properties in a renal cell line. J Cell Physiol 128: 71-75, 1986.
58. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. Activation of the ERK pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 6: 603-610, 2004.
59. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
60. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
61. Yano N, Endoh M, Nomoto Y, Sakai H, Fadden K, Rifai A. Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 17: 396-403, 1997.
62. Zandi-Nejad K, Eddy AA, Glassock RJ, Brenner BM. Why is proteinuria an ominous biomarker of progressive kidney disease? Kidney Int 66: S76-S89, 2004.
63. Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A. Comparative studies of oncostatin M expression in tissues of adult rodents. Anat Rec Part A 283A: 182-186, 2005.
64. Zoja C, Morigi M, Remuzzi G. Proteinuria and phenotypic change of proximal tubular cells. J Am Soc Nephrol 14: S36-S41, 2003.